Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the...